Drug profile · INN
acetophenazine maleate
TINDAL
acetophenazine maleate (TINDAL) is a dopamine d2 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — acetophenazine maleate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
acetophenazine maleate (TINDAL) is a dopamine d2 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine D2 receptor antagonist
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is acetophenazine maleate?
acetophenazine maleate (TINDAL) is a dopamine d2 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for acetophenazine maleate?
TINDAL is a marketed brand name for acetophenazine maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of acetophenazine maleate?
acetophenazine maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.